International Horizon Scanning Initiative To Level Pricing Playing Field
Transparency In Data Is A Key Concern
Nine countries are joining forces on horizon scanning with the aim of improving their chances of securing lower prices for high-cost drugs.
You may also be interested in...
Two groups of smaller European countries have agreed to collaborate on tackling challenges relating to accessing expensive new medicines.
Countries across the EU have been joining forces over the past few years to discuss and collaborate on pharmaceutical policy issues. They are hoping among other things to secure more sustainable drug prices and get a better grasp on what new medicines are on the horizon.
Francis Arickx from the cross-country coalition BeNeLuxA spoke this month about how the initiative had delivered proof of concept and discussed why uniting across borders is important for delivering access to transformative but expensive medicines.